STOCK TITAN

[Form 4] Avantor, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Avantor, Inc. director Gregory T. Lucier received a grant of 8,736 restricted stock units (RSUs) on 10/03/2025 that vest one year later on 10/03/2026. The grant was reported on a Form 4 filed by a single reporting person and shows an acquisition with a reported price of $0, consistent with equity awards issued as compensation rather than an open-market purchase. After the grant Lucier beneficially owns 8,736 shares of common stock directly. The Form 4 signature was executed by an attorney-in-fact on 10/07/2025.

Avantor, Inc. direttore Gregory T. Lucier ha ricevuto una concessione di 8.736 unità di azioni vincolate (RSU) il 10/03/2025 che vestono un anno più tardi il 10/03/2026. La concessione è stata riportata su un modulo Form 4 presentato da una singola persona informante e mostra un'acquisizione con un prezzo riportato di $0, coerente con premi azionari emessi come compenso anziché un acquisto sul mercato aperto. Dopo la concessione Lucier possiede beneficamente 8.736 azioni di azioni ordinarie direttamente. La firma del Form 4 è stata eseguita da un procuratore-in-fatto il 10/07/2025.

Avantor, Inc. el director Gregory T. Lucier recibió una asignación de 8.736 unidades de acciones restringidas (RSU) el 10/03/2025 que se consolidan un año despues el 10/03/2026. La concesión se informó en un Formulario 4 presentado por una única persona informante y muestra una adquisición con un precio reportado de $0, coherente con premios de acciones otorgados como compensación en lugar de una compra en el mercado abierto. Después de la concesión, Lucier posee beneficiosamente directamente 8.736 acciones de acciones comunes. La firma del Form 4 fue ejecutada por un apoderado el 10/07/2025.

Avantor, Inc. 이사 Gregory T. Lucier는 8,736주 제한 주식단위(RSU)10/03/2025에 받았으며 이는 10/03/2026에 1년 후에 vest합니다. 이 보상은 단일 보고인에 의해 Form 4에 보고되었고, 공개시장 매입이 아니라 보상으로 지급된 주식 수여에 해당하는 $0의 보고된 가격을 보여줍니다. 수여 후 Lucier는 직접적으로 8,736주의 보통주를 실질적으로 보유합니다. Form 4의 서명은 10/07/2025에 대리인에 의해 실행되었습니다.

Avantor, Inc. le directeur Gregory T. Lucier a reçu une attribution de 8 736 unités d'actions restreintes (RSU) le 10/03/2025 qui se libèrent un an plus tard le 10/03/2026. L'attribution a été déclarée sur un formulaire Form 4 soumis par une seule personne déclarante et montre une acquisition avec un prix reporté de $0, conforme à des attributions d'actions émises comme compensation plutôt qu'à un achat sur le marché ouvert. Après l'attribution, Lucier possède avantageusement directement 8 736 actions ordinaires. La signature du Form 4 a été réalisée par un mandataire le 10/07/2025.

Avantor, Inc. Direktor Gregory T. Lucier erhielt eine Zuteilung von 8.736 Restricted Stock Units (RSUs) am 10/03/2025, die am 10/03/2026 ein Jahr später vesten. Die Zuteilung wurde in Form 4 von einer einzelnen meldungspflichtigen Person gemeldet und zeigt einen Erwerb mit einem gemeldeten Preis von $0, im Einklang mit Eigenkapitalzuführungen, die als Vergütung vergeben wurden, statt eines Kaufs am offenen Markt. Nach der Zuteilung besitzt Lucier direkt rechtlich vorteilhaft 8.736 Aktien Stammaktien. Die Unterschrift des Form 4 wurde am 10/07/2025 von einem Bevollmächtigten ausgeführt.

Avantor, Inc. مدير Gregory T. Lucier تلقّى منحة من 8,736 وحدة أسهم مقيدة (RSU) في 10/03/2025 والتي تستحق في غضون عام واحد في 10/03/2026. تم الإبلاغ عن المنحة في نموذج Form 4 قدمه شخص واحد فقط ويُظهر اكتساباً بسعر مُبلغ عنه $0، وهو متسق مع الجوائز الأسهم الممنوحة كتعويض بدلاً من شراء في السوق المفتوحة. بعد المنحة، يمتلك Lucier مباشرة وبشكل مستفيد 8,736 سهماً من الأسهم العادية. تم تنفيذ توقيع نموذج 4 من قبل وكيل/ممثّل في 10/07/2025.

Avantor, Inc. 董事 Gregory T. Lucier 于 10/03/2025 收到一项 8,736 份受限股票单位(RSU) 的授予,该等单位将于一年后在 10/03/2026 生效。该授予在 Form 4 上由单一披露人提交,显示以 $0 的披露价格进行的获取,与作为补偿而发放的股票奖励而非公开市场购买相一致。授予后,Lucier 直接受益拥有 8,736 股 普通股。 Form 4 的签名于 10/07/2025 由代理人代为签署。

Positive
  • Director alignment with shareholders via a time‑based grant of 8,736 RSUs that vests on 10/03/2026
  • Compensation grant reported transparently on a Form 4 with direct beneficial ownership disclosed
Negative
  • No material negative developments disclosed; transaction is a routine director compensation grant

Insights

Director received time‑based RSUs totaling 8,736 that vest in one year.

The award reflects a common governance practice of granting restricted stock units to directors as deferred, time‑based compensation rather than immediate cash. The Form 4 shows the units were acquired at a reported price of $0, indicating the grant is a compensation issuance rather than a market purchase.

This transaction depends on continued service through 10/03/2026 to vest and creates a direct alignment between the director and shareholders over the vesting year. Investors may note the grant size of 8,736 RSUs when assessing director compensation levels relative to peers over the next 12 months.

Avantor, Inc. direttore Gregory T. Lucier ha ricevuto una concessione di 8.736 unità di azioni vincolate (RSU) il 10/03/2025 che vestono un anno più tardi il 10/03/2026. La concessione è stata riportata su un modulo Form 4 presentato da una singola persona informante e mostra un'acquisizione con un prezzo riportato di $0, coerente con premi azionari emessi come compenso anziché un acquisto sul mercato aperto. Dopo la concessione Lucier possiede beneficamente 8.736 azioni di azioni ordinarie direttamente. La firma del Form 4 è stata eseguita da un procuratore-in-fatto il 10/07/2025.

Avantor, Inc. el director Gregory T. Lucier recibió una asignación de 8.736 unidades de acciones restringidas (RSU) el 10/03/2025 que se consolidan un año despues el 10/03/2026. La concesión se informó en un Formulario 4 presentado por una única persona informante y muestra una adquisición con un precio reportado de $0, coherente con premios de acciones otorgados como compensación en lugar de una compra en el mercado abierto. Después de la concesión, Lucier posee beneficiosamente directamente 8.736 acciones de acciones comunes. La firma del Form 4 fue ejecutada por un apoderado el 10/07/2025.

Avantor, Inc. 이사 Gregory T. Lucier는 8,736주 제한 주식단위(RSU)10/03/2025에 받았으며 이는 10/03/2026에 1년 후에 vest합니다. 이 보상은 단일 보고인에 의해 Form 4에 보고되었고, 공개시장 매입이 아니라 보상으로 지급된 주식 수여에 해당하는 $0의 보고된 가격을 보여줍니다. 수여 후 Lucier는 직접적으로 8,736주의 보통주를 실질적으로 보유합니다. Form 4의 서명은 10/07/2025에 대리인에 의해 실행되었습니다.

Avantor, Inc. le directeur Gregory T. Lucier a reçu une attribution de 8 736 unités d'actions restreintes (RSU) le 10/03/2025 qui se libèrent un an plus tard le 10/03/2026. L'attribution a été déclarée sur un formulaire Form 4 soumis par une seule personne déclarante et montre une acquisition avec un prix reporté de $0, conforme à des attributions d'actions émises comme compensation plutôt qu'à un achat sur le marché ouvert. Après l'attribution, Lucier possède avantageusement directement 8 736 actions ordinaires. La signature du Form 4 a été réalisée par un mandataire le 10/07/2025.

Avantor, Inc. Direktor Gregory T. Lucier erhielt eine Zuteilung von 8.736 Restricted Stock Units (RSUs) am 10/03/2025, die am 10/03/2026 ein Jahr später vesten. Die Zuteilung wurde in Form 4 von einer einzelnen meldungspflichtigen Person gemeldet und zeigt einen Erwerb mit einem gemeldeten Preis von $0, im Einklang mit Eigenkapitalzuführungen, die als Vergütung vergeben wurden, statt eines Kaufs am offenen Markt. Nach der Zuteilung besitzt Lucier direkt rechtlich vorteilhaft 8.736 Aktien Stammaktien. Die Unterschrift des Form 4 wurde am 10/07/2025 von einem Bevollmächtigten ausgeführt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LUCIER GREGORY T

(Last) (First) (Middle)
RADNOR CORPORATE CENTER, BUILDING ONE,
SUITE 200, 100 MATSONFORD ROAD,

(Street)
RADNOR PA 19087

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Avantor, Inc. [ AVTR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/03/2025 A(1) 8,736 A $0 8,736 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects a grant of restricted stock units that vests on October 3, 2026.
Remarks:
/s/ Scott Baker, as Attorney-in-Fact 10/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Avantor (AVTR) report for Gregory T. Lucier on the Form 4?

Gregory T. Lucier was granted 8,736 restricted stock units on 10/03/2025, vesting on 10/03/2026, and now beneficially owns 8,736 shares.

Was the RSU grant purchased or issued as compensation for AVTR?

The Form 4 reports a transaction price of $0, indicating the RSUs were issued as compensation, not bought on the open market.

When do the 8,736 RSUs awarded to the director vest?

The RSUs vest on 10/03/2026, one year after the grant date of 10/03/2025.

How was the Form 4 filing signed for this AVTR transaction?

The filing bears a signature by Scott Baker as Attorney‑in‑Fact dated 10/07/2025.

Does the Form 4 show any derivative transactions for Gregory T. Lucier?

No derivative securities are listed; the filing reports only a non‑derivative grant of common stock RSUs.
Avantor

NYSE:AVTR

AVTR Rankings

AVTR Latest News

AVTR Latest SEC Filings

AVTR Stock Data

9.14B
657.64M
1.37%
106.68%
4.4%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR